Differential Posttreatment Outcomes of Methylphenidate for Smoking Cessation for Individuals With ADHD.

Sean X LuoLirio S CoveyMei-Chen HuTheresa M WinhusenEdward V Nunes

Published in: The American journal on addictions (2019)

OROS-MPH promotes abstinence beyond the course of treatment for patients with more severe ADHD, while the paradoxical effects in the lower baseline severity group is not persistent after medication discontinuation. Targeting ADHD in smoking cessation as a comorbidity therefore can have broader impact with more precise patient selection. (Am J Addict).

Keyphrases

smoking cessation
attention deficit hyperactivity disorder
replacement therapy
autism spectrum disorder
working memory
case report
early onset
cancer therapy
adverse drug
combination therapy
weight loss